Skip to content
healthcare.dev

DAYVIGO

NDC 62856-405, lemborexant, tablet, film coated, from Eisai Inc..

Product NDC
62856-405
Status
Listed
Labeler
Eisai Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212028
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62856-405 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEMBOREXANT5 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Orexin Receptor Antagonist [EPC]; Orexin Receptor Antagonists [MoA]

Package NDCNDC-11Package
62856-405-10628560405101 BLISTER PACK in 1 CARTON (62856-405-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
62856-405-306285604053030 TABLET, FILM COATED in 1 BOTTLE (62856-405-30)
62856-405-906285604059090 TABLET, FILM COATED in 1 BOTTLE (62856-405-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7074cb65-77b3-45d2-8e8d-da8dc0f70bfd
  • NADAC price for package 62856040530

    GET /v1/drugs/nadac/62856040530

Use it

Look up 62856-405 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62856-405 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62856-405. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.